Ho Tsui-Ting, Zhou Nanjiang, Huang Jianguo, Koirala Pratirodh, Xu Min, Fung Roland, Wu Fangting, Mo Yin-Yuan
Department of Pharmacology/Toxicology and Cancer Institute, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Department of Gastroenterology, Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, China.
Nucleic Acids Res. 2015 Feb 18;43(3):e17. doi: 10.1093/nar/gku1198. Epub 2014 Nov 20.
The CRISPR/Cas has been recently shown to be a powerful genome-editing tool in a variety of organisms. However, these studies are mainly focused on protein-coding genes. The present study aims to determine whether this technology can be applied to non-coding genes. One of the challenges for knockout of non-coding genes is that a small deletion or insertion generated by the standard CRISPR/Cas system may not necessarily lead to functional loss of a given non-coding gene because of lacking an open reading frame, especially in polyploidy human cell lines. To overcome this challenge, we adopt a selection system that allows for marker genes to integrate into the genome through homologous recombination (HR). Moreover, we construct a dual guide RNA vector that can make two cuts simultaneously at designated sites such that a large fragment can be deleted. With these approaches, we are able to successfully generate knockouts for miR-21, miR-29a, lncRNA-21A, UCA1 and AK023948 in various human cell lines. Finally, we show that the HR-mediated targeting efficiency can be further improved by suppression of the non-homologous end joining pathway. Together, these results demonstrate the feasibility of knockout for non-coding genes by the CRISPR/Cas system in human cell lines.
最近研究表明,CRISPR/Cas在多种生物体中是一种强大的基因组编辑工具。然而,这些研究主要集中在蛋白质编码基因上。本研究旨在确定该技术是否可应用于非编码基因。敲除非编码基因面临的挑战之一是,由于缺乏开放阅读框,标准CRISPR/Cas系统产生的小缺失或插入不一定会导致特定非编码基因的功能丧失,尤其是在多倍体人类细胞系中。为了克服这一挑战,我们采用了一种选择系统,该系统允许标记基因通过同源重组(HR)整合到基因组中。此外,我们构建了一种双向导RNA载体,它可以在指定位点同时进行两次切割,从而删除大片段。通过这些方法,我们能够在各种人类细胞系中成功敲除miR-21、miR-29a、lncRNA-21A、UCA1和AK023948。最后,我们表明,通过抑制非同源末端连接途径,可以进一步提高HR介导的靶向效率。总之,这些结果证明了CRISPR/Cas系统在人类细胞系中敲除非编码基因的可行性。